Case of Infantile Acute Hyperleukocytic Leukemia Treated by Leukapheresis
Author Information
Author(s): Bian Shuang, Li Nannan, Gao Hui
Primary Institution: Dalian Women and Children’s Medical Group, Dalian, China
Hypothesis
Leukapheresis is a feasible treatment option for acute hyperleukocytic leukemia in infants with ALL.
Conclusion
Leukapheresis effectively reduced the white blood cell count in a 6-month-old infant with acute hyperleukocytic leukemia, leading to recovery after chemotherapy.
Supporting Evidence
- Leukapheresis reduced the white blood cell count from 1,755 to 55 x 10^9/L.
- The infant showed an excellent prognosis after treatment.
- High-dose methotrexate chemotherapy was administered after leukapheresis.
Takeaway
Doctors used a special treatment called leukapheresis to help a very sick baby with too many white blood cells, and it worked well!
Methodology
The infant underwent two sessions of leukapheresis to reduce white blood cell count, followed by high-dose methotrexate chemotherapy.
Limitations
The efficacy of leukapheresis in very young patients remains controversial and the evidence is limited.
Participant Demographics
6-month-old Asian male infant.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website